NCT00004867

Positron Emission Tomography in Determining Stage of Esophageal Cancer

The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Carcinoma of the Thoracic Esophagus

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 235 (actual)
• Sponsor: Alliance for Clinical Trials in Oncology · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

RATIONALE: Imaging procedures such as positron emission tomography may improve the ability to determine the stage of esophageal cancer. PURPOSE: This clinical trial is studying how well fludeoxyglucose F 18 positron emission tomography determines tumor stage in patients with esophageal cancer.

Detailed description

OBJECTIVES: Primary Objective: To evaluate whether FDG-PET imaging can detect lesions that would preclude surgery (esophagectomy) in patients found to be surgical candidates by standard imaging procedures. Secondary Objective: To use the collected data to generate hypotheses to be used in future studies, such as which types of previously undetected lesions FDG-PET imaging is best able to identify.

Conditions

• Esophageal Cancer

Interventions

Type	Name	Description
PROCEDURE	conventional surgery
PROCEDURE	positron emission tomography
PROCEDURE	radionuclide imaging
RADIATION	fludeoxyglucose F 18
DRUG	chemotherapy
RADIATION	Radiotherapy

Timeline

• Start date: 1999-11-01
• Primary completion: 2005-07-01
• Completion: 2009-01-01
• First posted: 2003-01-27
• Last updated: 2017-01-24

Locations

35 sites across 1 country: United States